Erik K. Larsen

Also affiliated with Frederick Community College, Frederick National Laboratory for Cancer Research, National Cancer Institute, Leidos Biomedical Research Inc. (United States), Science Applications International Corporation (United States)

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Biophysical and structural analysis of KRAS switch-II pocket inhibitors reveals allele-specific binding constraints”.

Biophysical and structural analysis of KRAS switch-II pocket inhibitors reveals allele-specific binding constraints

Journal of Biological Chemistry(2025)10.1016/j.jbc.2025.110331

N/A

0.540DataRank · unranked

15 citations

Albert H. Chan, Dana Rabara, Monalisa Swain, Erik K. Larsen, Marcin Dyba +11 more

Structural basis for allosteric control of the SERCA-Phospholamban membrane complex by Ca2+ and phosphorylation

eLife(2021)10.7554/elife.66226

N/A

0DataRank · unranked

44 citations

U. Venkateswara Reddy, Songlin Wang, Erik K. Larsen, Tata Gopinath, Martin Gustavsson +5 more

Revealing the mechanism of action of a first-in-class covalent inhibitor of KRASG12C (ON) and other functional properties of oncogenic KRAS by 31P NMR

Journal of Biological Chemistry(2024)10.1016/j.jbc.2024.105650

N/A

0DataRank · unranked

21 citations

Jun Pei, Yue Yang, Marcin Dyba, Brian D. Smith, Dana Rabara +11 more